hit counter

ATP11B-YAP Pathway Improved Memory and Ferroptosis in Aged Mice

MHD featured image for ATP11B-YAP signaling, ferroptosis, mitochondrial dysfunction, and age-related cognitive decline in aged mice.

A 2026 mouse and cell study found that ATP11B loss pushed aged brains toward hippocampal iron accumulation, mitochondrial dysfunction, neuronal ferroptosis, and worse memory behavior than wild-type comparison mice; ATP11B overexpression then improved multiple learning and memory tests in 18-month-old mice. Research Highlights Memory signal: ATP11B-deficient mice performed worse than wild-type mice on Morris water …

Read more

REDDI MEG Classifier Separated 4 Neurodegenerative Diseases at 0.81

MHD featured image for REDDI MEG differential diagnosis research.

A 2026 medRxiv preprint found that REDDI, a resting-state magnetoencephalography machine-learning pipeline, separated mild cognitive impairment, multiple sclerosis, Parkinson’s disease, and amyotrophic lateral sclerosis with 0.81 ± 0.04 balanced accuracy across 5 folds.1 That is a meaningful jump over the prior 67.1% MEG benchmark, but it is still research-stage decision support rather than a clinical …

Read more

Antrodia Silver Nanoparticles Reduced Parkinsonism Markers in 63 Rats

MHD featured image for Antrodia silver nanoparticles and Parkinsonism oxidative-stress markers.

A 2026 Parkinsonism study involving 63 male rats found that Antrodia cinnamomea plus citrate-stabilized silver nanoparticles reduced 6-OHDA motor, oxidative-stress, inflammatory, α-synuclein, and apoptosis markers, while dopamine and acetylcholine recovery remained nonsignificant. The useful claim is a multitarget preclinical signal, not a Parkinson’s disease treatment recommendation. Research Highlights Combination treatment looked strongest: Tekiner et al. …

Read more

Alpha-Synuclein SAA Detected 95% of Lewy Body Dementia in ALZAN

MHD featured image for alpha-synuclein SAA and Lewy body dementia biomarkers.

A 2026 ALZAN memory-clinic cohort found that cerebrospinal-fluid alpha-synuclein seed amplification assay detected 19 of 20 Lewy body dementia cases, with 95% sensitivity and 93.5% specificity against non-Lewy-body, non-Alzheimer’s controls.1 The same assay was positive in 32 of 203 Alzheimer’s disease patients, which makes the result a co-pathology warning as much as a diagnostic win. …

Read more

ALS Anxiety: 18% State, 14% Trait in 433 Patients

MHD featured image for anxiety and depression in amyotrophic lateral sclerosis.

In 433 non-demented amyotrophic lateral sclerosis (ALS) patients, clinically significant anxiety was present in 18.2% for state anxiety and 13.9% for trait anxiety. The strongest predictor was not motor severity, cognition, or caregiver-rated behavior; it was depression, especially cognitive-affective depression symptoms.1 Research Highlights ALS anxiety was measurable but not universal: Aiello et al. found clinically …

Read more

Olfactory MRI Radiomics Link pTau217 to Alzheimer’s Cognition

MHD featured image for olfactory MRI radiomics, pTau217, and Alzheimer's disease cognitive impairment.

A 2026 multi-cohort Alzheimer’s disease study found that MRI radiomics from the hippocampus and amygdala linked plasma pTau217 and smell identification to cognitive impairment — with more added cognitive signal than simple regional volume. The result is useful because it points to a possible bridge between blood biomarkers and brain-circuit damage, but it is still …

Read more

iSupport-Malaysia Dementia Caregiver Program Scored 74.3 on Usability

A 2026 mixed-methods preprint found that iSupport-Malaysia, a multimedia web-based dementia caregiver psychoeducation program, reached a good System Usability Scale score of 74.3. That is enough to justify pilot testing, but not enough to claim caregiver mental-health benefit: 33.3% of usability-test participants failed sign-up, 20.0% failed search, and Loh et al. did not measure burden, …

Read more